Plain English with Derek Thompson15 Dec 2023

How Weight-Loss Drugs Could Impact U.S. Healthcare and Food. Plus, the Biggest Problems With GLP1s.

Today’s episode is our second in a series on the weight-loss drug revolution of the last two years. On Tuesday, we talked to endocrinologist Beverly Tchang about the science of glucagon like peptide 1 receptor agonists—also known as GLP1s, also known as Ozempic, Wegovy, Moujargo, and Zepbound. If you haven’t listened to that show, I think you’ll feel safe and entertained within the bounds of this episode. But if you want to know more about how these drugs work, their effect on insulin and glucose and the brain’s reward center, or the questions they raise about obesity and the nature of willpower and free will, I’d encourage you to queue up that show. Today, in Part 2, we have two guests: Zach Reitano is the CEO and cofounder of the telehealth platform Ro. He is here for a couple reasons. He has a bird’s-eye view of the GLP1 marketplace, the rise in demand, the supply chain, the economics of pricing and insurance. He’s also written several revelatory essays, pulling in research from think tanks, medical experts, and investment banks, that have helped shape my understanding of these drugs and the effect they could have on the population and the economy. Our second guest is Dr. Robert Lustig, an endocrinologist who spent years as a pediatrician and researcher at the University of California-San Francisco. As you’ll hear, he is much less optimistic about the ability of these drugs to revolutionize obesity medication in America. If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek Thompson Guests: Zach Reitano & Robert Lustig Producer: Devon Baroldi Learn more about your ad choices. Visit podcastchoices.com/adchoices

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(391)

A Philosopher’s One-Word Theory for Why the World Feels So Weird

Why does it feel like everything is more divided and exhausting than it used to be? Philosopher Agnes Callard has a surprisingly simple answer: the unicontext. It's her term for what happens when bill...

14 Juli 58min

How Israel Is Transforming American Politics

Peter Beinart joins Derek to unpack a major shift inside the Democratic Party. As Democratic Socialist-backed candidates notch a string of surprising primary victories, one issue has emerged as a defi...

7 Juli 1h 4min

MEGAPOD: The Most Overrated American Who Ever Lived

To celebrate America's 250th birthday, Derek is joined for a history draft by three of the country's leading historians: Beverly Gage, H.W. (Bill) Brands, and Richard White. The goal isn't to revisit ...

3 Juli 1h 9min

A Surprising Theory About the Future of War

From the bombing campaigns of World War II to the precision strikes of the modern era, for 80 years air power has defined modern warfare. But today, a new technology is changing the battlefield: drone...

30 Juni 56min

SpaceX, AI Bubble Fears, and The Age of the Trillion-Dollar, Zero-Profit Company

For decades, investors valued companies based on a familiar formula: Grow revenue, earn profits, and reward shareholders. But a new era may be beginning - one where trillion-dollar companies can lose ...

26 Juni 53min

The Iran War Is Ending. Everybody Lost.

Four months ago, the U.S. and Israel launched a surprise attack on Iran. Supporters predicted a decisive victory that would curb Iran’s nuclear ambitions and reshape the balance of power in the Middle...

23 Juni 56min

The Donald Trump Corruption Scandal Draft

What is Donald Trump good at? In his second administration, he promised lower prices, stronger manufacturing, and an end to foreign conflicts. Instead, inflation has risen, blue-collar job growth has ...

19 Juni 1h 8min

The Most Exciting Month of Medical Breakthroughs in Years

For years, scientists worried that medical progress was slowing down. Drug development became more expensive than ever with more complex clinical trials, and even then, many new treatments offered onl...

16 Juni 59min